Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1568 of 5804
-
New contrast mammogram spots hidden breast tumors
Diagnosis CompletedThis clinical trial investigates contrast-enhanced mammography (CEM) in detecting breast cancer. CEM is similar to standard mammography, but it includes an injection of an iodine-based contrast, which makes tissue and blood vessels more visible in scans. Diagnostic procedures, su…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 26, 2026 17:53 UTC
-
Can a phone app fix chemo brain? new study hopes so
Symptom relief OngoingThe overall purpose of this trial is to confirm the efficacy of Memory and Attention Adaptation Training (MAAT), a cognitive-behavioral therapy (CBT) for treatment of chemotherapy-related cognitive dysfunction among (female or male) breast cancer survivors. This is a multi-center…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New tool could predict who will suffer from steroid side effects
Knowledge-focused OngoingTo date, there is no available tool that allows, at individual level, determination of the probability to develop clinically relevant complications of prolonged glucocorticoid therapy. In patients with inflammatory rheumatic disorders requiring prolonged glucocorticoid therapy, s…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Blood test may shield cancer Patients' hearts from chemo damage
Disease control CompletedInvestigators will evaluate the safety and feasibility of a biomarker-guided cardioprotection strategy using NTproBNP, as compared to usual care, in breast cancer and lymphoma patients treated with anthracyclines.
Phase: PHASE1, PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New cocktail of drugs shows promise for tough lung cancer
Disease control OngoingThis phase Ib trial finds the best dose and side effects of ensartinib and its effects when given with carboplatin, pemetrexed and bevacizumab for in treating patients with ALK-positive non-small cell lung cancer that is stage IIIC or IV, or has come back (recurrent). Ensartinib …
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New combo attack: radiation plus surgery for stubborn tumors
Disease control Recruiting nowThe purpose of this study is to learn about the feasibility and safety of using Peptide Receptor Radionuclide Therapy (PRRT) before and after surgical removal of a tumor. PRRT treatment is based on the administration of a radioactive product, 177-Lu DOTA-0-Tyr3-Octreotate (Lutath…
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 26, 2026 15:13 UTC
-
New drug combo shows promise for tough lung cancers
Disease control CompletedThe objective of this study is to assess safety and efficacy of CAB-AXL-ADC in NSCLC
Phase: PHASE2 • Sponsor: BioAtla, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New hope for lung cancer: Drug-Radiation combo trial opens
Disease control Recruiting nowCONCORDE is a multi-institution, multi-arm, Phase IB study that will determine the recommended phase II dose (RP2D) and safety profiles of different DNA damage repair inhibitors (DDRis) when given in an open label fashion in combination with fixed dose curative intent radiotherap…
Phase: PHASE1 • Sponsor: University of Leeds • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Personalized vaccine plus immunotherapy shows promise for tough lung cancer
Disease control CompletedThis is a single-arm Phase Ib/II multicenter open-label study, with translational sub-study, of atezolizumab plus autologous dendritic cell vaccine as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC). It is expected that three Spanish sites will include p…
Phase: PHASE1, PHASE2 • Sponsor: Instituto Oncológico Dr Rosell • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a phone app beat the gold standard for weight loss?
Disease control OngoingThe overall objective of this study is to evaluate the first rigorously optimized, remotely delivered treatment for obesity against the current gold standard treatment in a head-to-head randomized controlled trial. The investigators will be comparing the previously developed and …
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug combo aims to tackle Hard-to-Treat multiple myeloma
Disease control TerminatedThis is a prospective, 2-arm (with an additional exploratory arm), open-label, multicenter study looking at the response rate of patients receiving selinexor (KPT-330), in combination with carfilzomib, daratumumab or pomalidomide. Multiple Myeloma patients with documented diseas…
Phase: PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Freezing and zapping: new combo therapy aims to ease bone cancer pain
Symptom relief Recruiting nowThis trial compares cryoablation combined with stereotactic body radiation therapy to stereotactic body radiation therapy alone to see how well they work in treating patients with pain from cancer that has spread to the bones (bone metastases). Bone is a common site of metastasis…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New study combines addiction treatment and IV antibiotics outside the hospital
Disease control CompletedThis study will assess the efficacy of an integrated outpatient treatment model for persons with opioid use disorder and injection related infections. The investigators hypothesize that outpatient antibiotic treatment coupled with comprehensive treatment for opioid use disorder w…
Phase: PHASE2 • Sponsor: Laura Fanucchi • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug aims to plug kidney leaks in multiple diseases
Disease control OngoingThe AFFINITY Study is a phase 2, open-label, basket study to evaluate the efficacy and safety of atrasentan in patients with proteinuric glomerular disease who are at risk of progressive loss of renal function.
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Sleep your way to better blood sugar: study tests personalized sleep extension to prevent diabetes
Prevention CompletedThis study will use continuous glucose monitoring and actigraphy to examine whether a personalized, daily sleep extension intervention improves glucose regulation for community dwelling, sleep-restricted adults with pre-diabetes. The randomized controlled trial will include 150 a…
Phase: NA • Sponsor: New York University • Aim: Prevention
Last updated Jun 26, 2026 13:47 UTC
-
Gut bacteria test could spot colon cancer early
Knowledge-focused CompletedThis observational study aims to help establish the first molecular test for non-invasive prediction of recurrent adenoma, which will help identify patients at high risk of recurrent adenoma for further colonoscopy examination, and validate the microbial test for CRC screening in…
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Zapping seizures away: targeted brain stimulation offers new hope for epilepsy
Disease control CompletedThis project aims to conduct a pilot study based on the targeting of the epileptogenic zone previously localized very precisely by stereoelectroencephalography (SEEG). SEEG is used as part of the pre-surgical assessment. It consists, thanks to the intracerebral implantation of el…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Tailored PTSD therapy boosts Veterans' daily life
Symptom relief CompletedRecent estimates suggest that over 610,000 US Veterans treated by the Veterans Health Administration (VHA) suffer from PTSD, a disorder that can be chronic and debilitating. The heterogeneity of the 20 symptoms of PTSD; comorbidity with disorders such as depression, panic, and su…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New combo pill aims to restore sexual function in men with prostate trouble
Symptom relief CompletedThe purpose of this study is to evaluate the efficacy and safety of Tanzânia association in adults with erectile dysfunction associated with Benign Prostatic Hyperplasia.
Phase: PHASE3 • Sponsor: EMS • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Blood test could help paramedics spot severe strokes before the hospital
Diagnosis CompletedTriage of acute ischemic stroke (AIS) patients is critical, to decrease time to treatment, and improve functional outcome. The therapeutic standard of care for AIS consecutive to large vessel occlusion (LVO) is the association of intravenous (IV) alteplase administration and mech…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 26, 2026 17:47 UTC